Valuation: Cogstate Limited

Market Cap 559M 387M 344M 321M 293M 551M 37.26B 3.89B 1.51B 18.98B 1.45B 1.42B 60.95B P/E 2027 *
26.9x
P/E 2028 * 21.6x
Enterprise Value 495M 343M 304M 284M 259M 488M 32.98B 3.44B 1.33B 16.79B 1.29B 1.26B 53.94B EV / Sales 2027 *
4.63x
EV / Sales 2028 * 3.89x
Free-Float
56.35%
Yield 2027 *
1.46%
Yield 2028 * 1.72%
1 day-3.24%
1 week-2.37%
Current month-3.52%
1 month+6.82%
3 months+21.40%
6 months+54.46%
Current year+45.58%
1 week 3.29
Extreme 3.29
3.46
1 month 2.95
Extreme 2.95
3.5
Current year 2.01
Extreme 2.01
3.5
1 year 1.75
Extreme 1.75
3.5
3 years 0.8
Extreme 0.795
3.5
5 years 0.8
Extreme 0.795
3.5
10 years 0.16
Extreme 0.155
3.5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/5/26 Buy

Director

3,600 0.0021%
20/5/26 Buy

Director

430 0.0003%
15/4/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-3.24%-2.37%+46.88%+118.60% 400M
+4.16%+3.04%+49.37%+94.17% 74.41B
-2.71%-3.10%+22.46%+75.37% 59.26B
+1.02%-0.67%+4.24%+34.46% 47.14B
-0.18%-4.11%+26.87%+33.72% 42.91B
-0.00%+1.00%+353.00%+691.06% 44.13B
-1.67%-1.71%+2.76%+98.70% 40.79B
+3.32%+3.49%+10.10%+51.23% 30.77B
-2.68%+2.92%+29.63%+22.72% 29.31B
-0.06%-8.00%-29.05%+327.30% 23.71B
Average -0.20%+0.02%+51.62%+154.73% 39.28B
Weighted average by Cap. +0.36%-0.31%+57.42%+150.49%

Financials

2027 *2028 *
Net sales 107M 74.04M 65.76M 61.5M 56.04M 106M 7.13B 744M 288M 3.63B 278M 272M 11.66B 123M 84.84M 75.35M 70.47M 64.21M 121M 8.17B 852M 330M 4.16B 319M 312M 13.36B
Net income 21.73M 15.04M 13.36M 12.49M 11.39M 21.44M 1.45B 151M 58.51M 738M 56.48M 55.25M 2.37B 26.88M 18.61M 16.53M 15.46M 14.09M 26.52M 1.79B 187M 72.39M 912M 69.87M 68.35M 2.93B
Net Debt -64.24M -44.47M -39.5M -36.94M -33.66M -63.37M -4.28B -447M -173M -2.18B -167M -163M -7B -81.78M -56.61M -50.28M -47.02M -42.85M -80.67M -5.45B -569M -220M -2.78B -213M -208M -8.92B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
02/10/26 $3.290 -3.24% 152,387
01/10/26 $3.400 -0.29% 127,382
30/09/26 $3.410 0.00% 1,436,554
29/09/26 $3.410 +3.02% 218,386
28/09/26 $3.310 -1.78% 259,372
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.400AUD
Average target price
4.312AUD
Spread / Average Target
+26.83%

Quarterly revenue - Rate of surprise